1. Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.
- Author
-
Franczak M, Prost RW, Antuono PG, Mark LP, Jones JL, and Ulmer JL
- Subjects
- Analysis of Variance, Aspartic Acid metabolism, Brain Chemistry, Case-Control Studies, Cognition Disorders pathology, Hippocampus pathology, Humans, Image Processing, Computer-Assisted, Neuropsychological Tests, Pilot Projects, Protons, Aspartic Acid analogs & derivatives, Cognition Disorders metabolism, Hippocampus metabolism, Inositol metabolism, Magnetic Resonance Spectroscopy methods
- Abstract
Objective: To assess the brain metabolites in the hippocampus of patients with mild cognitive impairment (MCI) using proton magnetic resonance spectroscopy at 0.5 T., Methods: Absolute concentrations and ratios to creatine of N-acetyl aspartate, myoinositol, glutamate + glutamine, and choline were measured in the right and left hippocampus of 5 MCI patients and 5 control subjects., Results: In MCI subjects, reduced N-acetyl aspartate was found in the right hippocampus (P = 0.01), and increased myoinositol was found in the left hippocampus (P = 0.02). Myoinositol/N-acetyl aspartate ratios were higher in the right (P = 0.03) and left (P = 0.01) hippocampus of MCI subjects. No significant difference in the concentration of glutamate + glutamine was observed between the control and MCI groups., Conclusions: An increase in myoinositol and a decrease in N-acetyl aspartate may be observed in the preclinical stages of dementia. Ratio measurements of these metabolites may serve as a biomarker for MCI.
- Published
- 2007
- Full Text
- View/download PDF